0001588978-24-000015.txt : 20240627 0001588978-24-000015.hdr.sgml : 20240627 20240627160728 ACCESSION NUMBER: 0001588978-24-000015 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 241079200 BUSINESS ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 6502329832 MAIL ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 10-Q/A 1 prct-20240331.htm 10-Q/A prct-20240331
000158897812/312024FALSEQ1xbrli:shares00015889782024-01-012024-03-3100015889782024-04-290001588978prct:FredericMollMember2024-01-012024-03-310001588978prct:FredericMollMember2024-03-310001588978prct:ShamShiblaqMember2024-01-012024-03-310001588978prct:ShamShiblaqMember2024-03-310001588978prct:AlalehNouriMember2024-01-012024-03-310001588978prct:AlalehNouriMember2024-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 1
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from   to
Commission file number 001-40797
PROCEPT BioRobotics Corporation
(Exact name of registrant as specified in its charter)
Delaware26-0199180
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
150 Baytech DriveSan JoseCA95134
(Address of Principal Executive Offices)(Zip Code)
(650) 232-7200
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.00001 par value per sharePRCTNasdaq Global Market
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  ☒   No  ☐ 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer  ☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes   ☐     No  ☒

The registrant had outstanding 51,424,151 shares of common stock as of April 29, 2024.




EXPLANATORY NOTE
This Amendment No. 1 on Form 10-Q/A (this “Amendment”) amends the Quarterly Report on Form 10-Q for PROCEPT BioRobotics Corporation (“Company”) for the period ended March 31, 2024 filed with the Securities and Exchange Commission on May 2, 2024 (the “Original Filing”). This Amendment is being filed to revise Part II “Item 5. Other Information” by adding two Rule 10b5-1 trading arrangements, one entered into by our Chief Commercial Officer adopted on March 9, 2024 and one adopted by our Chief Legal Officer on March 13, 2024, during the quarter ended March 31, 2024, which were inadvertently omitted from the disclosure included in the Original Filing.

In addition, as required by Rule 12b-15 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by the Company’s principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment, under Item 6 hereof, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. The Company is also not including new certifications under Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) (Section 906 of the Sarbanes-Oxley Act of 2002), as no financial statements are being filed with this Amendment.

Other than as expressly set forth herein, this Amendment does not, and does not purport to, amend, update or restate the information in Original Filing or reflect any events that have occurred after the Original Filing was made. Information not affected by this Amendment remains unchanged and reflects the disclosures made at the time as of which the Original Filing was made. No changes have been made to the financial statements of the Company as contained in the Original Filing. Accordingly, this Amendment should be read together with the Original Filing and the Company’s other filings with the SEC.

PART II
OTHER INFORMATION
Item 5. Other Information
During the quarter ended May 31, 2024, none of the director or officer of the Company informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K), except as follows:
On February 29, 2024, Frederic Moll, M.D., the Chair of the Company’s Board of Directors, terminated a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Moll 10b5-1 Plan”) under the Exchange Act, for the sale of shares of the Company’s common stock. The Moll 10b5-1 Plan was terminated during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Moll 10b5-1 Plan provided for the potential sale of up to 237,000 shares of the Company’s common stock, so long as the market price of the Company’s common stock was higher than certain minimum threshold prices specified in the Moll 10b5-1 Plan. The Moll 10b5-1 Plan was to expire on December 31, 2024, or on such earlier date on which all of the trades thereunder had been executed.
On March 9, 2024, Sham Shiblaq, the Company’s Chief Commercial Officer, adopted a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Shiblaq Rule 10b5-1 Plan”) under the Exchange Act, for the sale of shares of the Company’s common stock. The Shiblaq Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Shiblaq Rule 10b5-1 Plan provides for the potential sale of up to 26,046 shares of the Company’s common stock, including upon the exercise of vested stock options for shares of the Company’s common stock, so long as the market price of the
F-2

Company’s common stock is higher than certain minimum threshold prices specified in the Shiblaq Rule 10b5-1 Plan, between June 9, 2024 and December 31, 2024.
On March 13, 2024, Alaleh Nouri, the Company’s Chief Legal Officer, adopted a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Nouri Rule 10b5-1 Plan”) under the Exchange Act, for the sale of shares of the Company’s common stock. The Nouri Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Nouri Rule 10b5-1 Plan provides for the potential sale of up to 10,000 shares of the Company’s common stock, so long as the market price of the Company’s common stock is higher than certain minimum threshold prices specified in the Nouri Rule 10b5-1 Plan, between June 17, 2024 and June 17, 2025.

F-3

Item 6. Exhibits
The following exhibits are filed with this Quarterly Report on Form 10-Q/A.
Exhibit No.Exhibit Description
31.1
31.2
101iXBRL (Inline Extensible Business Reporting Language) for the information under Part II, “Item 5, Other Information” of this Amendment No. 1 on Form 10-Q/A.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).


F-4

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: June 27, 2024
PROCEPT BIOROBOTICS CORPORATION
(Registrant)
/s/ Reza Zadno
Reza Zadno, Ph.D.
President and Chief Executive Officer
(principal executive officer)
/s/ Kevin Waters
Kevin Waters
EVP, Chief Financial Officer
(principal financial and accounting officer)

F-5
 EX-31.1 2 prct-ex311soxcertification.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Reza Zadno, Ph.D., certify that:
1.I have reviewed this Quarterly Report on Form 10-Q/A of PROCEPT BioRobotics Corporation; and
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: June 27, 2024
By:/s/ Reza Zadno
Reza Zadno, Ph.D.
Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 3 prct-ex312soxcertification.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kevin Waters, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q/A of PROCEPT BioRobotics Corporation; and
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: June 27, 2024
By:/s/ Kevin Waters
Kevin Waters
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)

 EX-101.SCH 4 prct-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 prct-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 prct-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Entity Shell Company Entity Shell Company Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Pay vs Performance Disclosure [Line Items] Restatement Determination Date Restatement Determination Date All Trading Arrangements All Trading Arrangements [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent All Adjustments to Compensation All Adjustments to Compensation [Member] Sham Shiblaq [Member] Sham Shiblaq Award Timing Disclosures [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] All Individuals All Individuals [Member] All Award Types Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Compensation Amount Outstanding Recovery Compensation Amount Entity Filer Category Entity Filer Category Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Current Fiscal Year End Date Current Fiscal Year End Date Security Exchange Name Security Exchange Name MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Frederic Moll [Member] Frederic Moll PEO Name PEO Name Restatement Determination Date: Restatement Determination Date [Axis] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Insider Trading Arrangements [Line Items] Document Type Document Type Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Tabular List, Table Tabular List [Table Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Award Timing Method Award Timing Method [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Adoption Date Trading Arrangement Adoption Date PEO Total Compensation Amount PEO Total Compensation Amount Entity Central Index Key Entity Central Index Key Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Name Trading Arrangement, Individual Name Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net Income (Loss) Net Income (Loss) Attributable to Parent Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Entity Tax Identification Number Entity Tax Identification Number Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Alaleh Nouri [Member] Alaleh Nouri Title Trading Arrangement, Individual Title Executive Category: Executive Category [Axis] Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Name Measure Name Total Shareholder Return Amount Total Shareholder Return Amount Individual: Individual [Axis] Name Forgone Recovery, Individual Name Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Underlying Securities Award Underlying Securities Amount Measure: Measure [Axis] Entity Small Business Entity Small Business Name Outstanding Recovery, Individual Name Local Phone Number Local Phone Number Company Selected Measure Amount Company Selected Measure Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Exercise Price Award Exercise Price Name Awards Close in Time to MNPI Disclosures, Individual Name Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cover [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Non-NEOs Non-NEOs [Member] PEO PEO [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Non-PEO NEO Non-PEO NEO [Member] Adjustment to Compensation: Adjustment to Compensation [Axis] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Current Reporting Status Entity Current Reporting Status Other Performance Measure, Amount Other Performance Measure, Amount Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Arrangement Duration Trading Arrangement Duration Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Award Type Award Type [Axis] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Document Quarterly Report Document Quarterly Report All Executive Categories All Executive Categories [Member] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Trading Arrangement: Trading Arrangement [Axis] Termination Date Trading Arrangement Termination Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Entity File Number Entity File Number EX-101.PRE 7 prct-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover page - shares
 3 Months Ended
Mar. 31, 2024
Apr. 29, 2024
Cover [Abstract]    
Document Type 10-Q/A  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-40797  
Entity Registrant Name PROCEPT BioRobotics Corporation  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 26-0199180  
Entity Address, Address Line One 150 Baytech Drive  
Entity Address, City or Town San Jose  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95134  
City Area Code 650  
Local Phone Number 232-7200  
Title of 12(b) Security Common stock, $0.00001 par value per share  
Trading Symbol PRCT  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   51,424,151
Entity Central Index Key 0001588978  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Amendment Flag false  
Document Fiscal Period Focus Q1  
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Frederic Moll [Member]  
Trading Arrangements, by Individual  
Name Frederic Moll, M.D.
Title Chair of the Company’s Board of Directors
Rule 10b5-1 Arrangement Terminated true
Termination Date February 29, 2024
Aggregate Available 237,000
Sham Shiblaq [Member]  
Trading Arrangements, by Individual  
Name Sham Shiblaq
Title Chief Commercial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 9, 2024
Aggregate Available 26,046
Alaleh Nouri [Member]  
Trading Arrangements, by Individual  
Name Alaleh Nouri
Title Chief Legal Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 13, 2024
Aggregate Available 10,000
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 8 38 1 false 3 0 false 1 false false R1.htm 0000001 - Document - Cover page Sheet http://www.procept-biorobotics.com/role/Coverpage Cover page Cover 1 false false R2.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 2 false false All Reports Book All Reports prct-20240331.htm prct-20240331.xsd prct-20240331_def.xml prct-20240331_lab.xml prct-20240331_pre.xml http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "prct-20240331.htm": { "nsprefix": "prct", "nsuri": "http://www.procept-biorobotics.com/20240331", "dts": { "inline": { "local": [ "prct-20240331.htm" ] }, "schema": { "local": [ "prct-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "definitionLink": { "local": [ "prct-20240331_def.xml" ] }, "labelLink": { "local": [ "prct-20240331_lab.xml" ] }, "presentationLink": { "local": [ "prct-20240331_pre.xml" ] } }, "keyStandard": 38, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 3, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 8, "entityCount": 1, "segmentCount": 3, "elementCount": 126, "unitCount": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 17 }, "report": { "R1": { "role": "http://www.procept-biorobotics.com/role/Coverpage", "longName": "0000001 - Document - Cover page", "shortName": "Cover page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "prct-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "prct-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "prct-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "prct-20240331.htm", "first": true, "unique": true } } }, "tag": { "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r37" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r43" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r43" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r43" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r43" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r8", "r19", "r29", "r54" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r11", "r22", "r32", "r57" ] }, "prct_AlalehNouriMember": { "xbrltype": "domainItemType", "nsuri": "http://www.procept-biorobotics.com/20240331", "localname": "AlalehNouriMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Alaleh Nouri [Member]", "documentation": "Alaleh Nouri" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r43" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r50" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r15", "r23", "r33", "r50", "r58", "r62", "r70" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r68" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r65" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r66" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r61" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r61" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r61" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r61" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r61" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r61" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r64" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r63" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r62" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r62" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r41" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r42" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r42" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r47" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r46" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r48" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r45" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r3" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r36" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r75" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r44" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r8", "r19", "r29", "r54" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r5", "r16", "r26", "r51" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r50" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r12", "r23", "r33", "r58" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r12", "r23", "r33", "r58" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r12", "r23", "r33", "r58" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r12", "r23", "r33", "r58" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r12", "r23", "r33", "r58" ] }, "prct_FredericMollMember": { "xbrltype": "domainItemType", "nsuri": "http://www.procept-biorobotics.com/20240331", "localname": "FredericMollMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Frederic Moll [Member]", "documentation": "Frederic Moll" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r15", "r23", "r33", "r50", "r58", "r62", "r70" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r68" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r4", "r74" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r4", "r74" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r4", "r74" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r42" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r42" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r61" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r69" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r43" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income (Loss)", "label": "Net Income (Loss) Attributable to Parent" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r42" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r12", "r23", "r33", "r50", "r58" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r40" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r39" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r50" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r69" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r69" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r42" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r10", "r21", "r31", "r56" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r13", "r24", "r34", "r59" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r13", "r24", "r34", "r59" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r38" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r41" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r41" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r40" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r50" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r43" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r39" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r38" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r38" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r5", "r16", "r26", "r51" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r6", "r17", "r27", "r52" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r7", "r18", "r28", "r53" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r14", "r25", "r35", "r60" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r69" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r69" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "prct_ShamShiblaqMember": { "xbrltype": "domainItemType", "nsuri": "http://www.procept-biorobotics.com/20240331", "localname": "ShamShiblaqMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Sham Shiblaq [Member]", "documentation": "Sham Shiblaq" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r9", "r20", "r30", "r55" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r49" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r41" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r48" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r68" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r70" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.procept-biorobotics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r71" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r72" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r70" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r70" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r73" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r71" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r67" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r22": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r23": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r24": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r25": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r26": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r27": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r28": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r29": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r30": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r31": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r32": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r33": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r34": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r35": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r36": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r37": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r38": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r39": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r40": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r41": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r42": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r43": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r44": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r45": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r46": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r47": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r48": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r49": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r50": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r51": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r52": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r53": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r54": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r55": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r56": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r57": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r58": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r59": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r60": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r61": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r62": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r63": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r64": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r65": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r66": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r67": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r68": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r69": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r70": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r71": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r72": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r73": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r74": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r75": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" } } } ZIP 18 0001588978-24-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001588978-24-000015-xbrl.zip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prct:FredericMollMember 2024-01-01 2024-03-31 0001588978 prct:FredericMollMember 2024-03-31 0001588978 prct:ShamShiblaqMember 2024-01-01 2024-03-31 0001588978 prct:ShamShiblaqMember 2024-03-31 0001588978 prct:AlalehNouriMember 2024-01-01 2024-03-31 0001588978 prct:AlalehNouriMember 2024-03-31 shares 0001588978 --12-31 2024 false Q1 10-Q/A true 2024-03-31 false 001-40797 PROCEPT BioRobotics Corporation DE 26-0199180 150 Baytech Drive San Jose CA 95134 650 232-7200 Common stock, $0.00001 par value per share PRCT NASDAQ Yes Yes Large Accelerated Filer false false false 51424151 false false February 29, 2024 Frederic Moll, M.D. Chair of the Company’s Board of Directors true 237000 March 9, 2024 Sham Shiblaq Chief Commercial Officer true 26046 March 13, 2024 Alaleh Nouri Chief Legal Officer true 10000